Co-morbidity burden in Parkinson’s disease: Comparison with controls and its influence on prognosis

BACKGROUND: Many aspects of co-morbidity burden in Parkinson’s disease (PD) are unclear, but it may be an important predictor of prognosis or confounder of associations in epidemiological studies. OBJECTIVES: To determine how best to assess co-morbidity burden in PD, to compare with matched controls...

Descripción completa

Detalles Bibliográficos
Autores principales: Macleod, Angus D., Goddard, Hannah, Counsell, Carl E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925465/
https://www.ncbi.nlm.nih.gov/pubmed/27210815
http://dx.doi.org/10.1016/j.parkreldis.2016.05.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925465/
https://www.ncbi.nlm.nih.gov/pubmed/27210815
http://dx.doi.org/10.1016/j.parkreldis.2016.05.013

Ejemplares similares